A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Clinical trial NCT07668414 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07668414
Sponsor: Novo Nordisk A/S
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2026-09-22
Primary completion: 2028-10-10
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.